198 related articles for article (PubMed ID: 26519622)
1. The Updated Model: An Adjusted Serum Alpha-Fetoprotein-Based Algorithm for Hepatocellular Carcinoma Detection With Hepatitis C Virus-Related Cirrhosis.
White DL; Richardson P; Tayoub N; Davila JA; Kanwal F; El-Serag HB
Gastroenterology; 2015 Dec; 149(7):1986-7. PubMed ID: 26519622
[No Abstract] [Full Text] [Related]
2. A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis.
El-Serag HB; Kanwal F; Davila JA; Kramer J; Richardson P
Gastroenterology; 2014 May; 146(5):1249-55.e1. PubMed ID: 24462733
[TBL] [Abstract][Full Text] [Related]
3. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.
Zekri AR; Youssef AS; Bakr YM; Gabr RM; Ahmed OS; Elberry MH; Mayla AM; Abouelhoda M; Bahnassy AA
World J Gastroenterol; 2016 Apr; 22(16):4168-82. PubMed ID: 27122667
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of elderly hepatitis C virus-associated hepatocellular carcinoma patients.
Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Tada T; Tanaka J
J Gastroenterol Hepatol; 2013 Feb; 28(2):357-64. PubMed ID: 23190084
[TBL] [Abstract][Full Text] [Related]
5. The use of AFP-based algorithm to predict hepatocellular carcinoma.
Lo GH
Gastroenterology; 2014 Sep; 147(3):718. PubMed ID: 25075942
[No Abstract] [Full Text] [Related]
6. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.
Mazziotti G; Sorvillo F; Morisco F; Carbone A; Rotondi M; Stornaiuolo G; Precone DF; Cioffi M; Gaeta GB; Caporaso N; Carella C
Cancer; 2002 Dec; 95(12):2539-45. PubMed ID: 12467068
[TBL] [Abstract][Full Text] [Related]
7. Alpha-fetoprotein and p53 autoantibodies in patients with chronic hepatitis C.
Raedle J; Roth WK; Oremek G; Caspary WF; Zeuzem S
Dig Dis Sci; 1995 Dec; 40(12):2587-94. PubMed ID: 8536517
[TBL] [Abstract][Full Text] [Related]
8. Natural history of chronic hepatitis B REVEALed.
Chen CJ; Yang HI
J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
[TBL] [Abstract][Full Text] [Related]
9. Computer-aided assessment of hepatic contour abnormalities as an imaging biomarker for the prediction of hepatocellular carcinoma development in patients with chronic hepatitis C.
Goshima S; Kanematsu M; Kondo H; Watanabe H; Noda Y; Fujita H; Bae KT
Eur J Radiol; 2015 May; 84(5):811-5. PubMed ID: 25650331
[TBL] [Abstract][Full Text] [Related]
10. Comparison of hepatocellular carcinoma with cirrhosis patients undergoing hepatic resection between hepatitis B and C infection.
Shiba H; Ishida Y; Fujiwara Y; Wakiyama S; Gocho T; Ito R; lida T; Suzuki F; Furukawa K; Haruki K; Misawa T; Yanaga K
Hepatogastroenterology; 2013 Oct; 60(127):1746-8. PubMed ID: 24634946
[TBL] [Abstract][Full Text] [Related]
11. Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis.
Ravi S; Axley P; Jones D; Kodali S; Simpson H; McGuire BM; Singal AK
Gastroenterology; 2017 Mar; 152(4):911-912. PubMed ID: 28161225
[No Abstract] [Full Text] [Related]
12. Des-gamma-carboxyprothrombin is a favorable biomarker for the early diagnosis of alfa-fetoprotein-negative hepatitis B virus-related hepatocellular carcinoma.
Liu Z; Wu M; Lin D; Li N
J Int Med Res; 2020 Feb; 48(2):300060520902575. PubMed ID: 32054358
[TBL] [Abstract][Full Text] [Related]
13. Clinical Utility of Cytokeratins for Accurate Diagnosis of Hepatocellular Carcinoma Among Hepatitis C Virus High-Risk Patients.
Al Haddad M; El-Mezayen HA; El-Kassas M; Metwally F; El-Sharkawy A
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1325-1332. PubMed ID: 38679993
[TBL] [Abstract][Full Text] [Related]
14. Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis.
Arguedas MR; Chen VK; Eloubeidi MA; Fallon MB
Am J Gastroenterol; 2003 Mar; 98(3):679-90. PubMed ID: 12650806
[TBL] [Abstract][Full Text] [Related]
15. Ongoing alcohol consumptions counteracts the benefits of sustained virological response in patients with well compensated hepatitis C cirrhosis: an observational study.
Hernaez R; El-Serag H
Ann Hepatol; 2017 Jan-Feb 2017; 16(1):16-20. PubMed ID: 28051790
[No Abstract] [Full Text] [Related]
16. Community-based screening for hepatocellular carcinoma in elderly residents in a hepatitis B- and C-endemic area.
Huang YC; Huang CF; Chang KC; Hung SF; Wang JH; Hung CH; Chen CH; Tseng PL; Kee KM; Yen YH; Tsai PS; Tsai CC; Lu SN
J Gastroenterol Hepatol; 2011 Jan; 26(1):129-34. PubMed ID: 21175806
[TBL] [Abstract][Full Text] [Related]
17. Prospective screening increases the detection of potentially curable hepatocellular carcinoma: results in 8,900 high-risk patients.
Izzo F; Piccirillo M; Albino V; Palaia R; Belli A; Granata V; Setola S; Fusco R; Petrillo A; Orlando R; Tosone G; Scordino F; Curley SA
HPB (Oxford); 2013 Dec; 15(12):985-90. PubMed ID: 23607636
[TBL] [Abstract][Full Text] [Related]
18. Clinical course of chronic hepatitis C in patients with very high serum alpha-fetoprotein levels and normal hepatic imaging.
Gonzalez SA; Jacobson IM
Am J Gastroenterol; 2005 Apr; 100(4):977-8. PubMed ID: 15784045
[No Abstract] [Full Text] [Related]
19. Transient elastography for the detection of hepatocellular carcinoma in viral C liver cirrhosis. Is there something else than increased liver stiffness?
Feier D; Lupsor Platon M; Stefanescu H; Badea R
J Gastrointestin Liver Dis; 2013 Sep; 22(3):283-9. PubMed ID: 24078985
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis.
Patel D; Terrault NA; Yao FY; Bass NM; Ladabaum U
Clin Gastroenterol Hepatol; 2005 Jan; 3(1):75-84. PubMed ID: 15645408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]